University of Cape Town
Browse

Blood transcriptomic signatures for symptomatic TB in an African multi-cohort study: Public, subject-level signature scores, RT-qPCR data, and metadata

dataset
posted on 2024-05-03, 14:23 authored by Vanessa MuwangaVanessa Muwanga, Simon MendelsohnSimon Mendelsohn, Vinzeigh Leukes, Kim Stanley, Stanley KimbungStanley Kimbung, Mzwandile Erasmus, Marika Flinn, Tarryn-Lee Fisher, Rodney Raphela, Nicole Bilek, Stephanus T. Malherbe, Gerard TrompGerard Tromp, Gian van der Spuy, Gerhard Walzl, Novel N. Chegou, Thomas ScribaThomas Scriba

Here we provide the public, subject-level datasets containing key variables necessary to reconstruct findings from the ScreenTB and AE-TBC sub-studies aimed at evaluating the diagnostic performance of multiple parsimonious transcriptomic signatures. A data dictionary is provided below.

Gene expression of 20 transcriptomic signatures was measured in study participants from study sites located in six different African countries where the ScreenTB and AE-TBC studies were conducted. Gene expression data was generated from microfluidic RT-qPCR runs on mRNA derived from whole blood collected in PAXgene tubes. All results were verified before delta Ct values were calculated and used to compute signature scores.

The public dataset for the sub-study is divided into (1) subject-level signature scores, (2) subject-level TaqMan RT-qPCR primer-probe assay raw cycle threshold (CT) gene expression data from the Standard BioTools microfluidic gene expression integrated fluidic circuits, and (3) subject-level metadata.

Funding

Strategic Health Innovation Partnerships (SHIP) Unit of the South African Medical Research Council (SAMRC) with funds received from the South African Department of Science and Technology.

Evaluation of host biomarker-based point-of-care tests for targeted screening for active TB

European & Developing Countries Clinical Trials Partnership

Find out more...

European & Developing Countries Clinical Trials Partnership Programme (Grant Agreement Number IP_2009_32040).

History

Department/Unit

South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town